Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/95.C_N2kNfW.js ...

H.C. Wainwright analyst Ed Arce initiated coverage of NewAmsterdam Pharma (NAMS) with a Buy rating and $48 price target NewAmsterdam is a ...

美国心脏病学会（ACC）/美国心脏协会（AHA）和欧洲心脏病学会（ESC）均建议：对于确诊的动脉粥样硬化心血管疾病（ASCVD）患者使用高强度他汀类药物治疗，以将低密度脂蛋白胆固醇（LDL-C，俗称“坏胆固醇”）水平较基线至少降低50%。由于老年AS ...

betika jackpot bonus winners today 2022 The first generic drug in China! Fangsheng Pharmaceutical's "Ezetimibe Tablets" is ...

INR:7490. free horse betting tips FDA approves first continuous treatment to extend the lives of AML patients in first complete remission The first generi ...

Huadong Medicine's Anastrozole Tablets were approved The first generic drug in China! Fangsheng Pharmaceutical's "Ezetimibe Tablets" is approved for marketing Novartis settled the “kickback scandal” ...

Festa Junina Brazil outfits Eli Lilly invests €1.1 billion to develop RNA drugs for neurological diseases using exosome delivery technolog ...

game wala play store Kanghua Biopharma's listing on ChiNext: Rabies vaccines contribute more than 90% of revenue; stock price soars 44% on first day The first generic drug in China! Fangsheng ...

Did they escape the disaster temporarily? FDA approves Epidiolex for the treatment of epilepsy associated with tuberous sclerosis complex The first generic drug in China! Fangsheng Pharmaceutical's ...

Shares of NewAmsterdam Pharma (NASDAQ:NAMS – Get Free Report) have been assigned an average recommendation of “Buy” from the ...

NewAmsterdam Pharma (NASDAQ:NAMS – Get Free Report) major shareholder Nap B.V. Forgrowth sold 33,438 shares of NewAmsterdam ...

8316.T Sumitomo Mitsui Financial Group, Inc.